Back to Journals » Drug Design, Development and Therapy » Volume 12

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia

Total article views   HTML views PDF downloads Totals
40,732 Dovepress* 20,274+ 2,588 22,862
PubMed Central* 20,458 3,146 23,604
Totals 40,732 5,734 46,466
*Since 12 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
11 1 0 0 1 9

View citations on PubMed Central and Google Scholar